Duke Vaccine and Trials Unit — Durham, North Carolina

Duke Vaccine and Trials Unit is a clinical research site located in Durham, North Carolina, United States 27703.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Duke Vaccine and Trials Unit has participated in 21 clinical trials with 9 currently active.

Therapeutic areas: Avian Influenza, Influenza, Influenza Immunisation.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID), Pfizer, BioNTech SE.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke Vaccine and Trials Unit?

Duke Vaccine and Trials Unit has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke Vaccine and Trials Unit conducted?

Duke Vaccine and Trials Unit has 21 clinical trials on record, with 9 currently active. Their work covers Avian Influenza, Influenza, Influenza Immunisation.

Is Duke Vaccine and Trials Unit accredited by Crixeo Health?

Yes — Duke Vaccine and Trials Unit holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Duke Vaccine and Trials Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.